drugset / Trial / NCT00845858

Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis

NCT00845858

Phase 2 Completed 287 enrolled Evoke Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and the effectiveness of two doses of metoclopramide nasal spray solution, 10 mg and 14 mg, compared to placebo in reducing the symptoms of diabetic gastroparesis.

Timeline

Start
2009-04
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoclopramide Small molecule 10 mg Intranasal
Comparator Metoclopramide Small molecule 14 mg Intranasal